Recent posts
-
Patient Prostate Cancer Journey Part 3: Shared Decision-Making Benefits to Prostate Cancer Treatment
Each patient’s prostate cancer journey is unique. Read Part Three of Geoff McLennan’s story as he explores the benefits of shared decision-making with doctors.
-
Consistent data matters. Prolaris® is the best answer for your prostate cancer patients. Submit the form below to learn why.
-
American Cancer Society® Reports Increase in Late-Stage Prostate Cancer
-
How is the Prostate Gleason Score Graded? Your Biopsy and Gleason Score Part 2
-
Types of Prostate Biopsies: Your biopsy and Gleason score Part 1
-
Prostate cancer can be hereditary, get peace of mind with Myriad Genetic Testing
-
Patient PSA Test Primer: Best times to test and how to prepare
-
Prolaris® provides clarity for prostate cancer treatment decisions. A patient story.
-
Patient Prostate Cancer Journey Part 2: Getting to Active Surveillance
-
Patient Prostate Cancer Journey Part 1: A Urology Exam Reveals Unexpected Results
-
Can a genetic test improve prostate cancer treatment decisions? A patient story.
-
Consistent data matters. Prolaris® is the best answer for your prostate cancer patients. Submit the form below to learn why.
-
Myriad Genetics is committed to being your partner of choice
-
Understanding Prolaris test results